- $10.5 BnWorld market, 2023
- $22.9 BnProjected, 2033
- 8.1%Growth a year (CAGR)
- 157Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$4.4 Bn
6.1% a year · 42% of the world -
2
China
$844 Mn
9.6% a year · 8% of the world -
3
Canada
$840 Mn
8.1% a year · 8% of the world -
4
Japan
$653 Mn
8.6% a year · 6.2% of the world -
5
Germany
$384 Mn
6.3% a year · 3.7% of the world -
6
France
$289 Mn
7.1% a year · 2.8% of the world -
7
UK
$273 Mn
6.1% a year · 2.6% of the world -
8
Brazil
$263 Mn
9.1% a year · 2.5% of the world -
9
Italy
$252 Mn
7.6% a year · 2.4% of the world -
10
Ecuador
$210 Mn
8.7% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)
SpainMood and Stress Supplements by country and region
India
Saudi Arabia
Mexico
Australia
South Africa
UAE
Egypt
Philippines
Malaysia
Hong Kong
Singapore
Thailand
Kenya
New Zealand
Russia"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 24,718 papers since 2021
- The Microbiota-Short-Chain Fatty Acid Axis Mediates 6PPD-Q-Induced Intestinal Damage in Zebrafish at Environmentally Relevant Concentrations. Environmental pollution (Barking, Essex : 1987), 2026
- A meta-analysis on the prevalence of parents' complicated grief and post-traumatic stress disorder following perinatal loss in East and Southeast Asia. European journal of psychotraumatology, 2026
- Evaluation of the antitumor effects of banana extract alone and with doxorubicin in a rat model of breast cancer. Medical oncology (Northwood, London, England), 2026
- Clinical features of the postictal state in adults with epilepsy: A cross-sectional survey. Epilepsia, 2026
- [Nicotinamide adenine dinucleotide and male reproductive health]. Zhonghua nan ke xue = National journal of andrology, 2025
Compare Mood and Stress Supplements side by side
Key companies in Mood and Stress Supplements
Citracal
Dr Emil Nutrition
FutureBiotics
GNC Live Well
Mary Ruth Organics
Nature Made
Nature’s Way
Nutricost
Pure Synergy
Thorne
Quick answers
How big is the Mood and Stress Supplements market?
The world Mood and Stress Supplements market was worth about $10.5 Bn in 2023 and is projected to reach $22.9 Bn by 2033, growing 8.1% a year (CAGR).
Which country has the largest Mood and Stress Supplements market?
The US is the largest of the 24 countries we cover, at $4.4 Bn in 2023. India grows fastest, at 11.1% a year.
How many clinical trials are running in Mood and Stress Supplements?
ClinicalTrials.gov lists 157 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on Mood and Stress Supplements?
PubMed lists about 24,718 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.